GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Beilu Pharmaceutical Co Ltd (SZSE:300016) » Definitions » Total Long-Term Liabilities

Beijing Beilu Pharmaceutical Co (SZSE:300016) Total Long-Term Liabilities : ¥801 Mil (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Beijing Beilu Pharmaceutical Co Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Beijing Beilu Pharmaceutical Co's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ¥801 Mil.

Beijing Beilu Pharmaceutical Co Total Long-Term Liabilities Historical Data

The historical data trend for Beijing Beilu Pharmaceutical Co's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Beilu Pharmaceutical Co Total Long-Term Liabilities Chart

Beijing Beilu Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 611.96 532.67 592.72 673.94 692.82

Beijing Beilu Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 702.53 718.93 715.42 692.82 800.71

Beijing Beilu Pharmaceutical Co Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Beijing Beilu Pharmaceutical Co Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Beijing Beilu Pharmaceutical Co's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Beilu Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Beilu Pharmaceutical Co Ltd (SZSE:300016) » Definitions » Total Long-Term Liabilities
Comparable Companies
SZSE:301201 SZSE:002082 SHSE:688221 SZSE:000788 SZSE:300239 SHSE:603669 SHSE:603538 SZSE:002107 SZSE:300683 SZSE:002693 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 3, Shuiyuan West Road, Miyun District, Beijing, CHN, 100082
Website
http://www.beilu.com.cn
Beijing Beilu Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of pharmaceutical products. The products of the company are contrasted agent series, psychotropic, and hypoglycemic products which include iopamidol injection, iodixanol injection, and reglinide tablets.
Executives
Zong Li Directors, executives
Hong Cheng Jie Director
Duan Xian Zhu Directors, executives
Zhu Zhi Director
Wang Dai Xue Director
Li Hong Directors, executives
Liu Ning Directors, executives
Wu Rui Hua Directors, executives
Wu Jie Executives
Liu Dong Long Supervisors
Hong Wei Directors, executives

Beijing Beilu Pharmaceutical Co Headlines

No Headlines